Disruptive Behavior clinical trials at UC Health
1 in progress, 0 open to eligible people
Showing trials for
Prazosin for Agitation in Alzheimer's Disease
Sorry, not currently recruiting here
The study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease. Two thirds of the participants will participate in the medication portion, while one third will participate in the placebo portion
at UCLA UCSD
Last updated: